Schedule 13G ownership disclosure

ASSERTIO THERAPEUTICS INC

Security class unavailable · CUSIP: 04545L107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,529,527
Percent of class
8.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-20-000147
Form type
SC 13G/A
Filer
Assertio Therapeutics, Inc
CIK
CIK 1005201
Filed
Feb 13, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub